Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision (143) Apply European Commission final decision filter

Referral safety status

Yes (6) Apply Yes filter

Referral type

Article 29(4) referrals Remove Article 29(4) referrals filter Article 20 procedures Remove Article 20 procedures filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 31 referrals (116) Apply Article 31 referrals filter Article 30 referrals (95) Apply Article 30 referrals filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 107i procedures (8) Apply Article 107i procedures filter Article 13 referrals (6) Apply Article 13 referrals filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (18) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (20) Apply Centrally authorised product(s) filter Nationally authorised product(s) (9) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (12) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (2) Apply Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

143 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter

Referral type Article 20 procedures Remove Article 20 procedures filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 29(4) referrals Remove Article 29(4) referrals filter

Categories Human Remove Human filter

Sort by

List item

Referral: SGLT2 inhibitors

canagliflozin, dapagliflozin,empagliflozin, associated names: Edistride, Ebymect, Xigduo, Vokanamet, Synjardy, Jardiance, Invokana, Forxiga, Article 20 procedures
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 18/05/2016
List item

Referral: Tysabri

natalizumab, associated names: Tysabri, Article 20 procedures
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 25/04/2016, Last updated: 12/05/2016
List item

Referral: Tobramycin VVB and associated names

tobramycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/01/2015, EC decision date: 04/04/2016, Last updated: 04/05/2016
List item

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

Cervarix : Bivalent HPV vaccine (types 16, 18) -Gardasil : quadrivalent HPV vaccine (types 6, 11, 16, 18)Gardasil 9 : 9-valent HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)Silgard : quadrivalent HPV vaccine (types 6, 11, 16, 18), associated names: Cervarix, Gardasil, Gardasil 9, Silgard, Article 20 procedures
Status: European Commission final decision, opinion/position date: 19/11/2015, EC decision date: 12/01/2016, Last updated: 20/01/2016
List item

Referral: Inductos

dibotermin alfa, associated names: Inductos, Article 20 procedures
Status: European Commission final decision, opinion/position date: 22/10/2015, EC decision date: 20/11/2015, Last updated: 07/12/2015
List item

Referral: Merisone and associated names

tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, EC decision date: 25/06/2015, Last updated: 28/07/2015
List item

Referral: Myoson and associated names

tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, Last updated: 28/07/2015
List item

Referral: Iclusig

ponatinib, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 15/01/2015, Last updated: 02/03/2015
List item

Referral: Corlentor and Procoralan

ivabradine, associated names: Corlentor and Procoralan, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 15/01/2015, Last updated: 16/02/2015
List item

Referral: Seasonique and associated names

levonorgestrel / ethinylestradiol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 12/01/2015, Last updated: 29/01/2015
List item

Referral: Protelos and Osseor

strontium ranelate, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/02/2014, EC decision date: 15/04/2014, Last updated: 18/09/2014
List item

Referral: Dexamed and associated names

Dexamfetamine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 02/09/2014
List item

Referral: Nanotop and associated names

human albumin, denatured, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 28/02/2014, Last updated: 16/06/2014
List item

Referral: Kogenate Bayer and Helixate NexGen

octocog alfa, Article 20 procedures
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 20/02/2014, Last updated: 09/04/2014
List item

Referral: Tibolona Aristo and Tibocina and associated names

Tibolone, associated names: Tibolon Aristo, Tibolinia, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 05/03/2014, Last updated: 08/04/2014
List item

Referral: Valebo and associated names

alendronic acid and alfacalcidol, associated names: Tevabone, Teboneva, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 10/03/2014, Last updated: 31/03/2014
List item

Referral: Okrido

prednisolone sodium phosphate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 05/09/2013, Last updated: 03/01/2014
List item

Referral: Didanosine

didanosine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/09/2013, EC decision date: 20/11/2013, Last updated: 10/12/2013
List item

Referral: Methylphenidate Sandoz

methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, Last updated: 05/12/2013
List item

Referral: Methylphenidate Hexal

methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, Last updated: 05/12/2013
List item

Referral: Ciclosporin IDL

ciclosporin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 22/07/2010, Last updated: 20/11/2013
List item

Referral: Avalox

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013
List item

Referral: Furosemide Vitabalans

furosemide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/02/2013, EC decision date: 14/05/2013, Last updated: 30/07/2013
List item

Referral: Simvastatin Vale

simvastatin, associated names: Simvastatin Vale pharmaceuticals, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/03/2013, EC decision date: 27/05/2013, Last updated: 22/07/2013
List item

Referral: Tredaptive, Pelzont and Trevaclyn

laropiprant / nicotinic acid, Article 20 procedures
Status: European Commission final decision, EC decision date: 22/03/2013, Last updated: 17/05/2013

Load more

143 results

Referral: SGLT2 inhibitors

Referral: Tysabri

Referral: Tobramycin VVB and associated names

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

Referral: Inductos

Referral: Merisone and associated names

Referral: Myoson and associated names

Referral: Iclusig

Referral: Corlentor and Procoralan

Referral: Seasonique and associated names

Referral: Protelos and Osseor

Referral: Dexamed and associated names

Referral: Nanotop and associated names

Referral: Kogenate Bayer and Helixate NexGen

Referral: Tibolona Aristo and Tibocina and associated names

Referral: Valebo and associated names

Referral: Okrido

Referral: Didanosine

Referral: Methylphenidate Sandoz

Referral: Methylphenidate Hexal

Referral: Ciclosporin IDL

Referral: Avalox

Referral: Furosemide Vitabalans

Referral: Simvastatin Vale

Referral: Tredaptive, Pelzont and Trevaclyn